Design and Characterization of Nanostructure Lipid Carrier for Transdermal Delivery of Pioglitazone
DOI:
https://doi.org/10.37285/ijpsn.2018.11.4.6Abstract
Nanostructure Lipid Carrier (NLC) is one of the lipid-based drug delivery systems that are used as carrier for delivery of drugs. NLC are composed of mixture of solid lipid and liquid lipid, which form imperfect type of lipid matrix with improved drug loading capacity, drug release profile and stability. The aim of the present study was to develop and characterize nanostructure lipid carrier for transdermal delivery of pioglitazone (PZ) to overcome the problems related with oral route of administration and to improve systemic availability. NLC’s were prepared by high-speed homogenization method. Optimized NLC formulation was evaluated for particle size, percentage entrapment efficiency, surface morphology, DSC analysis, in-vitro drug release etc. The optimized NLC formulation was formulated as a transdermal patch and evaluated for in vitro drug release study and primary skin irritation study. In vivo hypoglycaemic activity of pioglitazone -NLC loaded transdermal patch was studied in comparison with its orally administered suspension. PZ- NLC loaded transdermal patch was found to be non-irritant and showed reduction in blood glucose level in a controlled manner up to 24 hrs.
Downloads
Metrics
Keywords:
Nanostructure lipid carrier, Pioglitazone, transdermal patch and hypoglycaemic activity.
Downloads
Published
How to Cite
Issue
Section
References
Dubey A, Prabhu P, and Kamath, J.V (2012). Nano Structured lipid carriers: A Novel Topical drug delivery system. International Journal of Pharm Tech Research. 4(2): 705-714.
Gowda DV, Sivadasu P, Shrivastava A, and Ali R (2016). Formulation and Evaluation of Nanostructure Lipid Carrier for Glimepiride. Der Pharmacia Letter. 8(7): 251-256.
Haider F, Kanoujia J, Tripathi C and Arya M (2015). Pioglitazone Loaded Vesicular Carriers for Anti-Diabetic Activity: Development and Optimization as Per Central Composite Design. Journal of Pharmaceutical Sciences and Pharmacology. (2): 11-20.
Kadam A, Ratnaparkhi M, and Chaudhry S (2014). Transdermal Drug Delivery: an overview. International Journal of Research and Development in Pharmacy and Life Sciences. 3 (4): 1042-1043.
Kaur S, and Nautyal U (2015). Nanostructure Lipid Carrier (NLC): the new generation of lipid nanoparticles. Asian Pacific Journal of Health Science. 2(2): 76-93.
Mehra Kavita and Geeverghese Rachel (2015). Formulation and Characterization of Nano- transferosomes of Famotidine in Transdermal Patch. International Journal of Pharmaceutical Sciences and Nanotechnology. 8(2): 2814-2822.
Mohammad W, Abdus S, Nazish I, Khale A, Mohod A, and Khan M (2013). Formulation Development Ex-Vivo and In- Vivo Evaluation of Nano- Emulsion for Transdermal Delivery of Glibenclamide. International Journal of Pharmacy and Pharmaceutical Science. 5(4): 747-754.
Nagaich U and Gulati N (2016). Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate. Design Drug Delivery and Translational Research. 6(2): 75-194.
Nair HA and Soni DM (2015). Optimization of formulation parameter for preparation of Docetaxel loaded nanostructure lipid carrier. International Journal of Pharmaceutical Science and Research. 6(7): 2846-2857.
Nair R and Arun Kumar K S (2011). Recent Advances in Solid Lipid Nanoparticles Based Drug Delivery Systems. Journal of Biomedical Science and Research. 3(2): 368-384.
Patel D and Chaudhari A (2012). Transdermal Drug Delivery System: A Review. Pharma Inovation. 1(4): 67-77.
Patel D and Dasgupta S (2012). Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation. Scientia Pharmceutica. 80: 749-764
Patel R, Singhal G, Prajapati B G and Patel N (2011). Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System. International Research Journal of Pharmacy. 2(2): 40-52.
Payasi M, Bhowmick M, Pandey G, Joshi A, and Dubey B (2013). Development and Characterization of Pioglitazone Loaded Liposphere for Effective Treatment of Diabetes Mellitus Type2. International Journal of Biomedical and Advance Research. 4(10): 738-749.
Posina A and Pandiya S (2011). Preparation in-vitro characterization of transdermal patch containing Glibenclamide and Atenolol. Pakistan Journal of Pharmaceutical Science. 24(2): 155-163.
Shekhawat P (2013). Preparation and Evalution of Nanostrcture Lipid Carrier for Topical drug delivery. International Journal of Pharma and Bio Sciences. 4(1): 407-416.
Shinde G, Rajesh KS, Prajapati N, and Murthy RS (2013). Formulation, Development and Characterization of Nanostrcture Lipid Carrier Loaded gel for psoriasis. Der Pharmacia Lettre, Scholar research libraray. 5(4):13-25.
Vijayan V, Jayachandran E, Anburaj J, and Rao D Srinivasa (2011). Transdermal Delivery of Repaglinide from solid Lipid Nanoparticles in Diabetic rats: In vivo and In vitro studies. Journal of Pharmaceutical Science and Research. (3): 1077-1081.
